The delays due to patient‘s and doctors‘ in non- small cell lung cancer patients

E. Radzikowska, P. Glaz, K. Roszkowski (Warsaw, Poland)

Source: Annual Congress 2003 - Lung cancer management and prognosis
Session: Lung cancer management and prognosis
Session type: Oral Presentation
Number: 2544
Disease area: Thoracic oncology

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Radzikowska, P. Glaz, K. Roszkowski (Warsaw, Poland). The delays due to patient‘s and doctors‘ in non- small cell lung cancer patients. Eur Respir J 2003; 22: Suppl. 45, 2544

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Small cell lung cancer in patients with elderly
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007



Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC)
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019


Small cell lung cancer patients and their responses to treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 301s
Year: 2004

Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

The role of palliative radiotherapy in locally advanced non small cell lung cancer
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007



Surgical management of patients with small cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 394s
Year: 2001

Rates of treatment response and median survival in advanced non small cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 302s
Year: 2004

Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC)
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009

Chemotherapy in advanced non small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 77s
Year: 2005

Clinical course of asymptomatic small enhancing brain nodules in patients with nonsmall cell lung cancer: do we have to follow them up?
Source: ERJ Open Res, 6 (3) 00109-2020; 10.1183/23120541.00109-2020
Year: 2020



Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007


Managing the initial treatment and multiple relapses in a small cell lung cancer patient with limited disease
Source: International Congress 2018 – CC3 Lung cancer: personalised treatment and palliative care
Year: 2018


Reflex testing  is crucial for treatment decisions in advanced non small cell lung cancer (NSCLC)
Source: International Congress 2017 – Chinese Programme 2017
Year: 2017

Lung cancer: does age affect treatment strategy?
Source: Eur Respir Mon; 2009: 43:306–326
Year: 2009

How do lung cancer patients die?
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Curative treatment vs. best supportive care in advanced non small cell lung cancer in aged person
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011